Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,382,700 | 3,008,500 | 3,862,800 | 2,758,800 | 2,598,300 |
| Marketable Securities | 900,000 | 807,200 | 97,600 | N/A | N/A |
| Receivables | 1,369,200 | 1,342,400 | 1,374,100 | 1,624,200 | 1,996,500 |
| Inventories | 1,949,000 | 2,168,100 | 2,209,400 | 2,274,300 | 2,273,900 |
| Other current assets | 1,589,500 | 1,647,900 | 1,392,700 | 1,310,400 | 757,300 |
| TOTAL | $9,190,400 | $8,974,100 | $8,936,600 | $7,967,700 | $7,626,000 |
| Non-Current Assets | |||||
| PPE Net | 3,017,900 | 3,055,400 | 3,075,700 | 3,098,800 | 3,132,400 |
| Investments And Advances | 1,243,100 | 1,182,500 | 729,700 | 637,700 | 559,100 |
| Intangibles | 15,542,200 | 15,669,600 | 15,822,600 | 15,960,600 | 16,061,700 |
| Other Non-Current Assets | 489,500 | 557,900 | 642,900 | 665,400 | 653,900 |
| TOTAL | $20,292,700 | $20,465,400 | $20,270,900 | $20,362,500 | $20,407,100 |
| Total Assets | $29,483,100 | $29,439,500 | $29,207,500 | $28,330,200 | $28,033,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 358,500 | 432,000 | 413,100 | 408,400 | 391,500 |
| Accrued Expenses | 2,546,800 | 2,802,600 | 2,773,600 | 2,660,500 | 2,530,700 |
| TOTAL | $2,998,900 | $3,349,400 | $3,290,000 | $3,183,700 | $5,297,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,288,500 | 6,286,800 | 6,285,100 | 6,283,700 | 4,548,700 |
| Other Non-Current Liabilities | 1,060,500 | 1,038,900 | 1,066,800 | 1,110,500 | 1,075,100 |
| TOTAL | $7,832,500 | $7,833,300 | $7,710,000 | $7,512,500 | $5,757,000 |
| Total Liabilities | $10,831,400 | $11,182,700 | $11,000,000 | $10,696,200 | $11,054,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 147,637 | 146,759 | 146,702 | 146,615 | 146,528 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 20,872,200 | 20,552,700 | 20,601,600 | 20,135,100 | 19,500,300 |
| Other shareholders' equity | -140,300 | -182,100 | -214,900 | -238,200 | -174,600 |
| TOTAL | $18,651,700 | $18,256,800 | $18,207,500 | $17,634,000 | $16,978,700 |
| Total Liabilities And Equity | $29,483,100 | $29,439,500 | $29,207,500 | $28,330,200 | $28,033,100 |